Eiger BioPharmaceuticals (EIGR)

11.03 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/13/18 *Est.)

Latest Headlines

Form 424B5 Eiger BioPharmaceuticals April 18, 2019 4:35 PM - SEC Filing Pre-Open Stock Movers 04/18: (MBIO) (URI) (CGC) Higher; (ATNM) (SNBR) (TEAM) Lower (more...) April 18, 2019 9:21 AM - StreetInsider Eiger BioPharmaceuticals (EIGR) Prices 4.5M Share Offering at $11/Sh April 18, 2019 5:43 AM - StreetInsider Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock April 17, 2019 10:53 PM - PR NewsWire After-Hours Movers 04/17: (MBIO) (URI) (CGC) Higher; (ATNM) (SNBR) (TEAM) (more...) April 17, 2019 5:49 PM - StreetInsider Form 424B5 Eiger BioPharmaceuticals April 17, 2019 4:08 PM - SEC Filing Eiger BioPharmaceuticals (EIGR) Commences Public Offering of Common Stock April 17, 2019 4:01 PM - StreetInsider Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock April 17, 2019 4:01 PM - PR NewsWire Form 8-K Eiger BioPharmaceuticals For: Apr 12 April 15, 2019 4:17 PM - SEC Filing Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors April 15, 2019 8:00 AM - PR NewsWire Eiger BioPharmaceuticals (EIGR) Reports 36% Durable Virologic Response at 24-Wk Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study April 11, 2019 4:10 PM - StreetInsider Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019 April 11, 2019 4:05 PM - PR NewsWire Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Apelian David March 26, 2019 10:24 AM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Shaffer James P March 26, 2019 10:13 AM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Cory David A March 26, 2019 10:08 AM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Murray Christine March 26, 2019 10:04 AM - SEC Filing Eiger BioPharmaceuticals to Participate in Conferences in April March 26, 2019 8:01 AM - PR NewsWire Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Mayer Eldon C. III March 25, 2019 10:01 PM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Dietz Thomas John March 25, 2019 9:55 PM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Glenn Jeffrey S March 25, 2019 9:53 PM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Loh Evan March 25, 2019 9:51 PM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Mar 21 Filed by: Patton Stephana Eilene March 25, 2019 9:48 PM - SEC Filing Form 3 Eiger BioPharmaceuticals For: Mar 18 Filed by: Patton Stephana Eilene March 25, 2019 9:46 PM - SEC Filing Eiger BioPharmaceuticals (EIGR) Highlights Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2019 Meetings March 25, 2019 1:34 PM - StreetInsider Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study Results of Avexitide in Post-Bariatric Hypoglycemia at Endocrine Society Meeting (ENDO) 2019 March 25, 2019 1:30 PM - PR NewsWire Eiger BioPharmaceuticals Management Team to Present and Participate in China Healthcare Investment Conference 2019 March 20, 2019 8:01 AM - PR NewsWire Form S-8 Eiger BioPharmaceuticals March 14, 2019 5:15 PM - SEC Filing Form 10-K Eiger BioPharmaceuticals For: Dec 31 March 14, 2019 4:20 PM - SEC Filing Form 8-K Eiger BioPharmaceuticals For: Mar 14 March 14, 2019 4:09 PM - SEC Filing Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update March 14, 2019 4:00 PM - PR NewsWire Eiger Late-Breaker Oral Presentation of Peginterferon Lambda Phase 2 LIMT Study at The International Liver Congress™ 2019 March 13, 2019 8:01 AM - PR NewsWire Eiger BioPharmaceuticals Management Team to Present and Participate in Jefferies HBV Investor Summit March 11, 2019 8:00 AM - PR NewsWire Form 8-K Eiger BioPharmaceuticals For: Mar 05 March 8, 2019 5:20 PM - SEC Filing Clinigen and Eiger BioPharmaceuticals Launch Worldwide Managed Access Program for Lonafarnib for Patients with Progeria and Progeroid Laminopathies March 4, 2019 7:00 AM - BizWire Eiger BioPharmaceuticals Announces the Appointment of Stephana Patton as General Counsel, Corporate Secretary, and Chief Compliance Officer February 27, 2019 8:02 AM - PR NewsWire Form SC 13G/A Eiger BioPharmaceuticals Filed by: HBM Healthcare Investments (Cayman) Ltd. February 14, 2019 4:27 PM - SEC Filing Form SC 13D/A Eiger BioPharmaceuticals Filed by: Vivo Ventures VI, LLC February 14, 2019 3:32 PM - SEC Filing Form SC 13G/A Eiger BioPharmaceuticals Filed by: EcoR1 Capital, LLC February 14, 2019 2:30 PM - SEC Filing Form SC 13G/A EIGER BIOPHARMACEUTICALS Filed by: 683 Capital Management, LLC February 14, 2019 11:43 AM - SEC Filing Form SC 13G/A Eiger BioPharmaceuticals Filed by: Prosight Management, LP February 14, 2019 9:08 AM - SEC Filing Form SC 13G/A Eiger BioPharmaceuticals Filed by: SPHERA FUNDS MANAGEMENT LTD. February 13, 2019 5:07 PM - SEC Filing Form SC 13G/A Eiger BioPharmaceuticals Filed by: PRUDENTIAL FINANCIAL INC February 7, 2019 8:41 AM - SEC Filing Form 4 Eiger BioPharmaceuticals For: Feb 04 Filed by: Cory David A February 6, 2019 7:24 PM - SEC Filing Form SC 13D/A Eiger BioPharmaceuticals Filed by: INTERWEST PARTNERS X LP February 6, 2019 4:09 PM - SEC Filing Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan February 6, 2019 8:00 AM - PR NewsWire Eiger BioPharmaceuticals Announces Oral Presentation of Phase 2 PREVENT Study of Avexitide in Post-Bariatric Hypoglycemia (PBH) at Upcoming Endocrine Society (ENDO) Meeting 2019 in New Orleans February 4, 2019 8:00 AM - PR NewsWire Form SC 13G/A Eiger BioPharmaceuticals Filed by: JENNISON ASSOCIATES LLC January 31, 2019 12:17 PM - SEC Filing Form SC 13D/A Eiger BioPharmaceuticals Filed by: INTERWEST PARTNERS X LP January 29, 2019 3:24 PM - SEC Filing Baird Starts Eiger BioPharma (EIGR) at Outperform January 28, 2019 4:09 PM - StreetInsider Full Article List